Jump to content

Vaccines

Latest Additions

Uncovering popular misconceptions about generalised HIV/AIDS epidemics
( J. D. Shelton / The Lancet , 2007)

This editorial from the Lancet outlines ten commonly held misconceptions about HIV epidemics that impede prevention efforts.

...
Commitment, cooperation and coordination between government and scientific communities needed for AIDS vaccine
( J-L. Excler / Indian Journal of Medical Research , 2005)
This article, from the Indian Journal of Medicine, argues that development of an AIDS vaccine, which represents the only long-term hope in stopping the epidemic, faces a number of substantive challen...
White House policy supports intellectual property rights to support vaccine development
( White House Council of Economic Advisors , 2005)
This chapter, from the White House Policy on HIV and AIDS, describes the global epidemic and outlines current American policy aimed at tackling it. The chapter discusses the nature of the crisis and i...
World Bank is well placed to encourage greater investment in AIDS vaccine development
( World Bank , 2000)
This paper presents the findings and recommendations of the World Bank AIDS Vaccine Task Force, formed in April 1998 to identify how the institution can accelerate the development of an AIDS vaccine f...
Possible behavioural responses to the introduction of an HIV/AIDS vaccine in Uganda
( D. Bishai; G Pariyo; M. Ainsworth; K. Hill / Bulletin of the World Health Organization : the International Journal of Public Health , 2004)
This study focuses on two issues concerning the introduction of a preventative HIV/AIDS vaccine in Uganda: what are the key factors that will lead adults to accept a vaccine; and what are possible beh...
The feasibility of delivering an HIV-1 vaccine in Southern India
( S. Seshadri; P. Subramaniyam; P. Jha / World Bank , 2003)
This paper assesses the potential demand for and strategic use of an HIV- 1 vaccine in southern India. It assesses the size of potential high- and low-risk target groups for an HIV-1 vaccine in the 11...
Injecting caution: re-thinking vaccination for HIV-positive Ugandans
( Neil French;Charles Gilks / id21 Development Research Reporting Service , 2002)
Infection with the bacterium, Streptococcus pneumoniae, is a frequent and serious problem for HIV-infected adults. A polysaccharide vaccine is currently licensed and available, and is recommended in t...
Cost and impact of HIV/AIDS in Brazil: cost of treatment versus economic burden of illness
( H.M.D. Novaes; E.J.A. Luna; M. Goldbaum; S. Kilsztajn; A. Rossbach; J. de la Rocha Carvalheiro / World Bank , 2002)
This study assesses the potential demand by the public sector for a preventive HIV/AIDS vaccine in Brazil and the costs of alternative strategies for a vaccination program.

The study reviews the cos...

Increased risk behaviour due to the presence of an HIV vaccine: undoing the good in Southern India
( N.J.D. Nagelkerke; S.J. De Vlas / World Bank , 2003)
This paper examines the potential epidemiological impact of preventive HIV vaccines on the HIV epidemic in Southern India using a mathematical deterministic dynamic compartmental model.

Various assu...

Prioritising vaccine administration in Southern Africa
( C. Desmond; R. Greener / World Bank , 2003)
This paper investigates the issues around the targeting of an eventual HIV vaccine.

The authors identify potential target groups for a vaccine, and estimate how many individuals would be in need of ...

Results 1 to 10 of 23

More on Vaccines

Subscribe

Regular email updates. What’s new on the subjects you are interested in.

More

Contribute

Share your publications. Advertise your jobs and events

More

Newsfeed

xmlAdd Eldis content to your website, intranet or desktop.